Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to extend cash

.Turnstone Biologics is actually reducing its headcount through 60% as well as shaking up its C-suit...

Gilead gives up on $15M MASH wager after mulling preclinical data

.In a year that has actually viewed an authorization as well as a raft of readouts for metabolic dys...

Texas biotech axes cancer cells treaty, pins really hopes on weight problems

.Alaunos Rehabs is axing an agreement with Precigen, giving up licensing legal rights to a tailored ...

Capricor portions a lot more records for DMD treatment after initiating BLA

.Capricor Therapeutics is actually taking a success lap for their phase 2 Duchenne muscular dystroph...

FDA areas Kezar lupus trial in hold following 4 patient fatalities

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus trial on grip after the biotech fla...

Phase 3 Intellectual Rock trial reaches SMA objective, delivering stock up 200%

.A stage 3 trial of Scholar Rock's spinal muscular degeneration (SMA) candidate has reached its prim...

CAMP 4 is most current to eye IPO, while Upstream spells out $182M program

.RNA biotech CAMP4 Therapies has defined prepare for a $67 thousand IPO, along with inflammation-foc...

Galecto purchases leukemia medication, drops bone cancer possession in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis candidate delivered Galecto on a loo...

Judo throws down $100M to knock senseless kidney illness

.Taking the floor covering is actually Judo Bio, a promising biotech equipped with $100 million to b...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid off CSPC Drug Group $one hundred million for a preclinical heart atta...